Evidence of inhibiting effect of curcumin complex and aspirin combination in colorectal cancer: study

eec03b9c-27ed-4f21-9295-35f6627c2ca6articleimage.jpg

30 Oct 2017 --- Researchers have found evidence of the inhibitory effect in colon tumorigenesis of a low dose combination of aspirin and Sabinsa’s Curcumin C3 Complex. The findings have been published in the journal Biochemical Pharmacology.

Colorectal cancer (CRC) is one of the major causes of human mortality and morbidity. Colitis-accelerated colon cancer (CAC) is a sub-type of CRC that is also closely associated with inflammatory bowel disease (IBD). Although aspirin has been widely investigated as a chemopreventive agent for CAC and different types of CRC, the potential side-effect of gastrointestinal bleeding has been a concern in long-term high-dose aspirin therapy.  

In this new study on animals, researchers at Rutgers discovered that co-administration of Curcumin C3 Complex and aspirin helps to lower the dose of aspirin by 50 percent rendering this therapy feasible without adverse effects. It has been known earlier that Curcumin C3 complex is non-toxic at all tested doses.

Additionally, aspirin and C3 Complex combination modulated larger gene sets than the single agent treatment. These genes were involved in several canonical pathways important in the inflammatory network and liver metastasis in CAC. Also, this was the first study is first of its kind in an Azoxymethane(AOM)/DSS (Dextran sulfate sodium)-induced CAC.

“Extensive research on Curcumin C3 Complex continues to reveal additional applications and benefits, which fosters further studies added to the large body of science on C3 Complex,” says Sabinsa founder Dr. Muhammed Majeed. “The range of health benefits scientific investigation has identified continues to inspire researchers across the globe.”

At Vitafoods Asia 2017, NutritionInsight spoke with Sabinsa  CEO Shaheen Majeed about curcumin and other trending nutritionals. Curcumin, one of the natural compounds present in the turmeric rhizomes has been a focus of clinical investigations for management of several life style diseases or conditions such as Alzheimer, arthritis, liver disorders, hangovers, inflammation, hypercholesterolemia and asthma. With increasing research into biological functions and activities of curcumin, another area of curcumin biology is gaining a lot of attention – its metabolites

Earlier this month, Sabinsa’s parent company Sami Labs inaugurated a second Continuous Extraction Plant to meet the demand for Curcumin C3 Complex. This new facility will be exclusively used for curcumin extraction, increasing production of Curcumin C3 Complex to 25 tons from the previous capacity of 6 tons. The two Continuous Extraction units are spread across 5 acres in Dobaspet, Bangalore, India. 

Related Articles

Nutrition & Health News

Drink your vitamins: SternVitamin launches micronutrient premix for beverages 

19 Feb 2018 --- A healthy lifestyle is essential to all age groups, and nutrition plays a major role alongside various other components. SternVitamin is now offering beverage manufacturers a novel way to address the topic of health with a new micronutrient premix for healthy bones and heart. SternVitamin notes that the mix picks up on one of the top trends in the beverage market – water-based enriched products. The vegan premix contains vitamins B1, B12, C, K2 and D3. Organic agave syrup powder gives it a slight sweetness, while natural flavors give the drink a “dark berry” taste. It dissolves clear in water and leaves no turbidity. 

Nutrition & Health News

Yogurt may reduce cardiovascular disease risk

19 Feb 2018 --- A higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women, a study in the American Journal of Hypertension suggests. High blood pressure is a major cardiovascular disease risk factor. Clinical trials have previously demonstrated beneficial effects of dairy consumption on cardiovascular health, and yogurt may independently be related to cardiovascular disease risk.

Nutrition & Health News

“Unhelpful”: EU regulatory framework fuels nutrition industry dissatisfaction 

16 Feb 2018 --- A survey reveals that one-third of all nutrition industry professionals believe that the current EU framework for achieving a health claim on new products is stunting innovation because it’s complicated, expensive, long-winded and has several “gray areas.” And “regulation frustration” is a strong feeling running through the industry with many more professionals now believing the current EU regulatory environment is “unhelpful” – a 25 percent hike compared with statistics from the beginning of 2017. Experts are attributing this sharp rise in dissatisfaction to the EU’s tough stance on health claims and the current regulatory deadlock on botanicals.

Nutrition & Health News

Indulgence has reached even America’s healthiest eaters: research

16 Feb 2018 --- New research reveals even the US’ healthiest eaters reach for indulgence foods based on their emotional states. Forty percent of US food-brand lovers who rated their daily diet as extremely healthy agreed with the statement, “When I’m feeling down, I eat something indulgent to make me feel better.” The study, conducted by full-service food branding agency, Foodmix Marketing Communications, breaks out a large group of brand lovers into smaller, differentiated and more actionable consumer segments.  

Nutrition & Health News

Research driving demand for OPO in China’s formula market: Advanced Lipids

16 Feb 2018 --- OPO is increasing in popularity in China’s infant formula market, and according to Advanced Lipids, this is down to the growing body of scientific research backing the benefits of this ingredient. Also known as SN-2 palmitate, OPO is a premium quality ingredient that mimics the fatty acid profile of human milk.

More Articles
URL : http://www.nutritioninsight.com:80/news/evidence-of-inhibiting-effect-of-curcumin-complex-and-aspirin-combination-in-colorectal-cancer-study.html